News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,576 Results
Type
Article (26407)
Company Profile (60)
Press Release (368107)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104538)
Career Advice (455)
Deals (16903)
Drug Delivery (53)
Drug Development (47992)
Employer Resources (47)
FDA (12355)
Job Trends (8485)
News (186702)
Policy (19533)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1765)
Accelerated approval (14)
Adcomms (11)
Allergies (110)
Alliances (26876)
ALS (96)
Alzheimer's disease (1069)
Antibody-drug conjugate (ADC) (161)
Approvals (12689)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6895)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3060)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (43120)
Collaboration (852)
Compensation (271)
Complete response letters (16)
COVID-19 (1555)
CRISPR (35)
C-suite (485)
Cystic fibrosis (59)
Data (4245)
Decentralized trials (2)
Denatured (20)
Depression (94)
Diabetes (317)
Diagnostics (3721)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (95)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38691)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54332)
Executive appointments (584)
FDA (14637)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (11)
Funding (756)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (543)
Government (3142)
Grass and pollen (4)
Guidances (231)
Healthcare (12237)
HIV (38)
Huntington's disease (21)
IgA nephropathy (50)
Immunology and inflammation (82)
Immuno-oncology (25)
Indications (67)
Infectious disease (1686)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7078)
IRA (23)
Job creations (1845)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3648)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (289)
MASH (105)
Medical device (13297)
Medtech (13342)
Mergers & acquisitions (10335)
Metabolic disorders (751)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (174)
Neuropsychiatric disorders (44)
Neuroscience (1801)
NextGen: Class of 2026 (3941)
Non-profit (2839)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (141)
Pancreatic cancer (140)
Parkinson's disease (169)
Partnered (17)
Patents (225)
Patient recruitment (350)
Peanut (42)
People (35674)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12377)
Phase 2 (18686)
Phase 3 (15300)
Pipeline (3037)
Policy (125)
Postmarket research (1673)
Preclinical (3838)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (428)
Real estate (2871)
Recruiting (18)
Regulatory (15696)
Reports (18)
Research institute (1660)
Resumes & cover letters (49)
Rett syndrome (17)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (118)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2137)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (503)
Venture capital (28)
Weight loss (210)
Women's health (54)
Worklife (4)
Date
Last 7 days (305)
Last 30 days (1042)
Last 365 days (16186)
2026 (1478)
2025 (16531)
2024 (19968)
2023 (22821)
2022 (30765)
2021 (33061)
2020 (32240)
2019 (28458)
2018 (21851)
2017 (18951)
2016 (18145)
2015 (21230)
2014 (16052)
2013 (13266)
2012 (14370)
2011 (14641)
2010 (13187)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25512)
Australia (4030)
California (5579)
Canada (1910)
China (782)
Colorado (285)
Connecticut (287)
Delaware (249)
Europe (49932)
Florida (958)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (383)
Iowa (11)
Japan (317)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (898)
Massachusetts (3789)
Michigan (149)
Minnesota (442)
Mississippi (6)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1923)
New Mexico (10)
New York (1580)
North Carolina (810)
North Dakota (4)
Northern California (2646)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1365)
Puerto Rico (11)
Rhode Island (36)
South America (523)
South Carolina (59)
Southern California (2244)
Tennessee (124)
Texas (1017)
United States (21727)
Utah (195)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,576 Results for "synaptive medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Synaptive Medical Welcomes Chris Marrus as New Chief Commercial Officer
Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, is proud to announce the appointment of Chris Marrus as Chief Commercial Officer.
February 29, 2024
·
3 min read
Funding
Karuna, Naurex Alumni Launch New Biotech
to Modulate Synaptic Plasticity for Neuro Diseases
With $90 million to start, Syndeio has a lead asset in Phase II clinical trials for major depressive disorder, with plans to soon launch a biomarker trial in Alzheimer’s disease.
May 27, 2025
·
3 min read
·
Heather McKenzie
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
Synaptive Medical Inc. has received 510(k) clearance from the Food and Drug Administration (FDA) for its Near-Infrared fluorescence visualization module, Modus IR, adding to the existing fluorescence offering on its 4K 3D robotic exoscope, Modus X.
March 27, 2024
·
2 min read
Synaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual Meeting
Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, will showcase its near-infrared fluorescence visualization setting, Modus IR, at this year’s American Association of Neurological Surgeons (AANS) meeting, taking place in Chicago, Illinois, from May 3 – 6.
April 30, 2024
·
2 min read
Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities
Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund.
August 2, 2023
·
2 min read
Business
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors
Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.
August 10, 2023
·
2 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Press Releases
Cognito Therapeutics Announces Spectris™ Treatment Demonstrates Myelin and Synaptic Biomarker Changes in Alzheimer’s Disease
February 11, 2025
·
3 min read
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR
Synaptive Medical Inc. announced a joint-development partnership with bioelectronic medicine company Panaxium SAS to incorporate Panaxium’s ultra-flexible iontronic electrocorticography platform into Synaptive’s Modus V robotic exoscope technology.
October 11, 2022
·
4 min read
Synaptive Announces U.S. and Canadian Availability of Next-Generation Robotic-Exoscope, Modus X
Synaptive Medical Inc., a global medical technology innovator, announced FDA registration for the next-generation of its robotic exoscope.
March 22, 2023
·
2 min read
1 of 39,458
Next
